Aylin Akifova
aylinink.bsky.social
Aylin Akifova
@aylinink.bsky.social
Junior doctor and researcher currently focused on kidney transplants @ChariteBerlin
Happy to be part of the „Tour de France académique“ series from @markusathome.bsky.social 🇫🇷🇩🇪🧑🏽‍🔬 We shared some thoughts on the future implications of novel invasive & non-invasive biomarkers in transplantation!
Watch „Diagnosis of Allograft Rejection Today&Tomorrow“🔬🧬👇🏼
m.youtube.com/watch?v=cqe3...
Watch our next stop on YouTube:
Diagnosis of Allograft Rejection Today & Tomorrow - Dr. Olivier Aubert, Dr. Aylin Akifova

@olivieraubert.bsky.social @aylinink.bsky.social

youtu.be/cqe3R3Q9B4Y?...
July 18, 2025 at 8:43 PM
Reposted by Aylin Akifova
Watch our next stop on YouTube:
Diagnosis of Allograft Rejection Today & Tomorrow - Dr. Olivier Aubert, Dr. Aylin Akifova

@olivieraubert.bsky.social @aylinink.bsky.social

youtu.be/cqe3R3Q9B4Y?...
July 18, 2025 at 6:42 PM
Reposted by Aylin Akifova
A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus-associated complications

doi.org/10.1016/j.kint.2025.06.014

#MedSky #NephSky #kidneytransplantation #bkvirus #TxID
July 8, 2025 at 1:56 PM
Among the ESOT2025 highlights: Gregor Bond‘s talk on biomarkers to guide the personalisation of the management of organ recipients! State of the art & future to do’s to move the field forward! Results from the recently completed TTV-Guide RCT project loading soon! #ttvguide 🧬@gregorbond.bsky.social
July 2, 2025 at 2:28 PM
Reposted by Aylin Akifova
Antibody-mediated Rejection - Treatment Standard

doi.org/10.1093/ndt/...
May 29, 2025 at 5:59 PM
Reposted by Aylin Akifova
Here we are with AI in medicine 🤖 #medsky

In this @jama.com single-blinded, multicenter RCT, including 149 patients with type 2 DM (inpatient), the real-time AI-assisted Insulin titration system for glucose control was noninferior to senior endocrinology physicians

jamanetwork.com/journals/jam...
May 8, 2025 at 2:52 PM
Reposted by Aylin Akifova
#KIControversies in Nephrology
Clinical utility of donor-derived cell-free DNA 🧬testing for kidney transplant monitoring in selected patients
You can read the
✅Point
✅Counterpoint
✅Editor's summary
in the May issue of KI
doi.org/10.1016/j.kint.2025.01.039

#MedSky #NephSky #kidneytransplant
May 7, 2025 at 5:48 PM
Hot off the press! 🗞️ We are happy to share some very important critical thoughts around dd-cfDNA testing in kidney transplantation wrapped up in a point & counterpoint paper as part of „Controversies in nephrology“ now published in @kidneyint.bsky.social
www.kidney-international.org/article/S008...
Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients
To date, we still rely on a few established biomarkers, such as creatinine, proteinuria, and human leukocyte antigen antibodies for the surveillance of renal allografts.1,2 Over the last few years, do...
www.kidney-international.org
April 19, 2025 at 11:56 AM
Check out our latest paper from @ChariteBerlin that provides insights into the dynamics of absolute and relative dd-cfDNA measured by droplet digital PCR in diverse kidney allograft pathologies! Now online on Transplantation Direct:
journals.lww.com/transplantat...
April 11, 2025 at 12:06 PM